Skip to main content
Equibles

Canal Insurance CO

Insurance

Position in EXEL — Exelixis, Inc.

CIK 1313473 Greenville, SC
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$1,088,200
+$230,400 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#334
of 756 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Canal Insurance CO holds $8,015,554 across 4 Biotechnology names. EXEL ranks #4 (13.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NTLA
Intellia Therapeutics, Inc.
 230,000 $3,891,600
2 CRSP
CRISPR Therapeutics AG
 35,100 $1,914,354
3 RPRX
Royalty Pharma plc
 20,000 $1,121,400
4 EXEL
Exelixis, Inc.
This page 		20,000 $1,088,200

All Filings in EXEL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,088,200 20,000
2026-03-31 $857,800 20,000